{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:28:00Z","timestamp":1764174480469,"version":"3.40.1"},"reference-count":17,"publisher":"WHO Press","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bull. World Health Organ."],"published-print":{"date-parts":[[2018,3,1]]},"DOI":"10.2471\/blt.17.199414","type":"journal-article","created":{"date-parts":[[2018,2,27]],"date-time":"2018-02-27T11:34:00Z","timestamp":1519731240000},"page":"173-184F","source":"Crossref","is-referenced-by-count":36,"title":["National policies on the management of latent tuberculosis infection: review of 98 countries"],"prefix":"10.2471","volume":"96","author":[{"given":"Ann","family":"Jagger","sequence":"first","affiliation":[{"name":"University of California Berkeley, School of Public Health, Berkeley, California, United States of America."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silke","family":"Reiter-karam","sequence":"additional","affiliation":[{"name":"Global Tuberculosis Programme, World Health Organization, Avenue Appia 20, 1211 Geneva 27, Switzerland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohhei","family":"Hamada","sequence":"additional","affiliation":[{"name":"Global Tuberculosis Programme, World Health Organization, Avenue Appia 20, 1211 Geneva 27, Switzerland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haileyesus","family":"Getahun","sequence":"additional","affiliation":[{"name":"Global Tuberculosis Programme, World Health Organization, Avenue Appia 20, 1211 Geneva 27, Switzerland."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1305","published-online":{"date-parts":[[2018,2,5]]},"reference":[{"journal-title":"Global tuberculosis report.","year":"2017","key":"key-10.2471\/BLT.17.199414-201802271233-R1"},{"issue":"9979","key":"key-10.2471\/BLT.17.199414-201802271233-R2","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1016\/S0140-6736(15)60570-0","article-title":"WHO\u2019s new end TB strategy.","volume":"385","author":"Uplekar","year":"2015","journal-title":"Lancet"},{"issue":"22","key":"key-10.2471\/BLT.17.199414-201802271233-R3","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1056\/NEJMra1405427","article-title":"Latent Mycobacterium tuberculosis infection.","volume":"372","author":"Getahun","year":"2015","journal-title":"N Engl J Med"},{"journal-title":"Framework towards tuberculosis elimination in low-incidence countries.","year":"2014","key":"key-10.2471\/BLT.17.199414-201802271233-R4"},{"issue":"4","key":"key-10.2471\/BLT.17.199414-201802271233-R5","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/j.1440-1843.2010.01751.x","article-title":"Treatment of latent tuberculosis infection: An update.","volume":"15","author":"Lobue","year":"2010","journal-title":"Respirology"},{"key":"key-10.2471\/BLT.17.199414-201802271233-R6","unstructured":"Badje AD, Moh R, Gabillard D, Guehi C, Kabran M, Menan H, et al. Six-month IPT reduces mortality independently of ART in African adults with high CD4. Abstract Number: 78. In: Conference on Retroviruses and Opportunistic Infections, 13\u201316 February 2017, Seattle, United States of America. San Francisco: CROI Foundation; 2017."},{"issue":"9","key":"key-10.2471\/BLT.17.199414-201802271233-R7","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1056\/NEJMoa1507198","article-title":"A trial of early antiretrovirals and isoniazid preventive therapy in Africa.","volume":"373","author":"Danel","year":"2015","journal-title":"N Engl J Med"},{"issue":"5","key":"key-10.2471\/BLT.17.199414-201802271233-R8","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1183\/13993003.00449-2016","article-title":"Advancing global programmatic management of latent tuberculosis infection for at risk populations.","volume":"47","author":"Getahun","year":"2016","journal-title":"Eur Respir J"},{"journal-title":"Recommendations for investigating contacts of persons with infectious tuberculosis in low- and middle-income countries.","year":"2012","key":"key-10.2471\/BLT.17.199414-201802271233-R9"},{"journal-title":"Guidelines for intensified case-finding and isoniazid preventative therapy for people living with HIV in resource-constrained settings.","year":"2011","key":"key-10.2471\/BLT.17.199414-201802271233-R10"},{"journal-title":"Guidelines on the management of latent tuberculosis infection.","year":"2015","key":"key-10.2471\/BLT.17.199414-201802271233-R11"},{"issue":"6","key":"key-10.2471\/BLT.17.199414-201802271233-R12","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1183\/13993003.01245-2015","article-title":"Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries.","volume":"46","author":"Getahun","year":"2015","journal-title":"Eur Respir J"},{"issue":"12","key":"key-10.2471\/BLT.17.199414-201802271233-R13","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.5588\/ijtld.16.0241","article-title":"Policies and practices on the programmatic management of latent tuberculous infection: global survey.","volume":"20","author":"Hamada","year":"2016","journal-title":"Int J Tuberc Lung Dis"},{"key":"key-10.2471\/BLT.17.199414-201802271233-R14","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1097\/01.aids.0000391023.03037.1f","article-title":"Implementation of isoniazid preventive therapy for people living with HIV worldwide: barriers and solutions.","volume":"24","author":"Getahun","year":"2010","journal-title":"AIDS"},{"issue":"10","key":"key-10.2471\/BLT.17.199414-201802271233-R15","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.5588\/ijtld.13.0889","article-title":"Review of policy and status of implementation of collaborative HIV-TB activities in 23 high-burden countries.","volume":"18","author":"Gupta","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"journal-title":"Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings.","year":"2011","key":"key-10.2471\/BLT.17.199414-201802271233-R16"},{"key":"key-10.2471\/BLT.17.199414-201802271233-R17","unstructured":"Richtlijn behandeling latente tuberculose-infectie. Den Haag: KNVC Tuberculosis Foundation; 2015. Dutch. Available from: https:\/\/www.nvalt.nl\/kwaliteit\/richtlijnen\/infectieziekten\/\/Infectieziekten\/KNCV%20Richtlijn%20Behandeling%20latente%20tuberculose-infectie%202015.pdf [cited 2018 Jan 5]."}],"container-title":["Bulletin of the World Health Organization"],"original-title":[],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T17:20:06Z","timestamp":1742404806000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5840630\/pdf\/BLT.17.199414.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,5]]},"references-count":17,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,2,5]]},"published-print":{"date-parts":[[2018,3,1]]}},"URL":"https:\/\/doi.org\/10.2471\/blt.17.199414","relation":{},"ISSN":["0042-9686"],"issn-type":[{"type":"print","value":"0042-9686"}],"subject":[],"published":{"date-parts":[[2018,2,5]]}}}